Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 25,005
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12616681 | Compositions and methods for treating renal injury | 🖼🧊📄§ | 2026-05-05 | 2042-08-22 | 0 | 31 |
| 12616677 | Injectable pharmaceutical compositions and uses thereof | 🖼🧊📄§ | 2026-05-05 | 2040-05-01 | 0 | 31 |
| 12616678 | Methods to of aldehyde dehydrogenases for treatment of cancer | 🖼🧊📄§ | 2026-05-05 | 2041-06-10 | 0 | 31 |
| 12616689 | Regimens of tafenoquine for prevention of malaria in malaria-naive subjects | 🖼🧊📄§ | 2026-05-05 | 2043-08-30 | 0 | 31 |
| 12616690 | Specific AKT3 activator and uses thereof | 🖼🧊📄§ | 2026-05-05 | 2044-03-15 | 0 | 31 |
| 12616687 | Treatment of viral infection, disease or disorder using a selective sir agonist | 🖼🧊📄§ | 2026-05-05 | 2042-11-04 | 0 | 31 |
| 12616700 | Therapeutic regimen | 🖼🧊📄§ | 2026-05-05 | 2043-07-07 | 0 | 31 |
| 12616698 | Methods for reducing liver fat and for treating fatty liver disorders | 🖼🧊📄§ | 2026-05-05 | 2043-11-22 | 0 | 31 |
| 12616697 | Methods of treatment with myosin modulator | 🖼🧊📄§ | 2026-05-05 | 2041-08-26 | 0 | 31 |
| 12616708 | Methods for treating pulmonary non-tuberculous mycobacterial infections | 🖼🧊📄§ | 2026-05-05 | 2044-11-07 | 0 | 31 |
| 12616722 | Treatment of immune disorders | 🖼🧊📄§ | 2026-05-05 | 2045-01-17 | 0 | 31 |
| 12616725 | Bifidobacterium breve IDCC 4401 strain and its dead cell ID-BBR4401 having excellent acid tolerance and bile tolerance and prophylactic or therapeutic effect on dyslipidemia | 🖼🧊📄§ | 2026-05-05 | 2042-12-30 | 0 | 31 |
| 12616724 | Pharmaceutical composition for preventing or treating intestinal damage comprising Leuconostoc citreum strain as active ingredient | 🖼🧊📄§ | 2026-05-05 | 2042-02-07 | 0 | 31 |
| 12616731 | Process for enhancing organoleptic properties of natural products and natraceuticals thereof | 🖼🧊📄§ | 2026-05-05 | 2041-09-22 | 0 | 31 |
| 12616732 | Peptides for treatment of medical disorders | 🖼🧊📄§ | 2026-05-05 | 2042-07-11 | 0 | 31 |
| 12616746 | Infectious disease antigens and vaccines | 🖼🧊📄§ | 2026-05-05 | 2042-10-03 | 0 | 31 |
| 12616753 | HSP70 inhibitors and methods of using same | 🖼🧊📄§ | 2026-05-05 | 2041-03-30 | 0 | 31 |
| 12616752 | Pharmaceutical compositions comprising meloxicam | 🖼🧊📄§ | 2026-05-05 | 2045-06-05 | 0 | 31 |
| 12616761 | CXCR4-targeting compounds | 🖼🧊📄§ | 2026-05-05 | 2044-06-27 | 0 | 31 |
| 12616684 | Pulmonary fibrosis medicine containing pyrazole derivative | 🖼🧊📄§ | 2026-05-05 | 2041-03-23 | 0 | 31 |
| 12616705 | Use of cannabinoids in the treatment of Angelman syndrome | 🖼🧊📄§ | 2026-05-05 | 2043-05-02 | 0 | 31 |
| 12616706 | Compositions and methods of use comprising substances with neural plasticity actions administered at non-psychedelic/psychotomimetic dosages and formulations | 🖼🧊📄§ | 2026-05-05 | 2040-03-06 | 0 | 31 |
| 12616741 | Therapeutic combination comprising a pulmonary surfactant and a steroid for the prophylaxis of BPD | 🖼🧊📄§ | 2026-05-05 | 2041-03-17 | 0 | 31 |
| 12616661 | Composition for type II diabetics and for use in providing sustained energy release over time | 🖼🧊📄§ | 2026-05-05 | 2039-03-07 | 0 | 31 |
| 12617827 | Self-assembling peptide | 🖼🧊📄§ | 2026-05-05 | 2041-07-29 | 0 | 31 |
| 12617857 | Chemokine receptor 4 (CXCR4) antagonist antibodies | 🖼🧊📄§ | 2026-05-05 | 2041-04-22 | 0 | 31 |
| 12617846 | Subcutaneous (SC) administration of anti-C5 antibodies for treatment of complement-associated conditions | 🖼🧊📄§ | 2026-05-05 | 2041-05-06 | 0 | 31 |
| 12617862 | Anti-CD73 antibody and application thereof | 🖼🧊📄§ | 2026-05-05 | 2040-08-20 | 0 | 31 |
| 12617823 | Broad-spectrum peptide antigen of the novel coronavirus SARS-COV-2, specific neutralizing antibody and use thereof | 🖼🧊📄§ | 2026-05-05 | 2041-07-21 | 0 | 31 |
| 12616755 | Antifungal quercetin conjugates, methods of preparation and uses thereof | 🖼🧊📄§ | 2026-05-05 | 2045-10-08 | 0 | 31 |
| 12616652 | Lenses for treating ocular diseases and preparation method thereof | 🖼🧊📄§ | 2026-05-05 | 2042-12-29 | 0 | 31 |
| 12616745 | Influenza virus backbone | 🖼🧊📄§ | 2026-05-05 | 2040-06-05 | 0 | 31 |
| 12616749 | Methods for treatment of psoriasis with an anti-oxLDL antibody | 🖼🧊📄§ | 2026-05-05 | 2044-06-21 | 0 | 31 |
| 12616782 | Use of mitochondria to treat and/or prevent tendon injury or its related disease | 🖼🧊📄§ | 2026-05-05 | 2041-03-19 | 0 | 31 |
| 12616721 | Stratified squamous epithelial cell normal differentiation and maturation promoting agent, epithelial disease therapeutic agent, and stratified squamous epithelial cell normal differentiation and maturation promoting method | 🖼🧊📄§ | 2026-05-05 | 2039-01-11 | 0 | 31 |
| 12616696 | Crystalline forms of (p)-3-chloro-4-((3,5-difluoropyridin-2-yl)methoxy)-2′-(2-(2-hydroxypropan-2-yl)pyrimidin-4-yl)-5′,6-dimethyl-2h-[1,4′-bipyridin]-2-one | 🖼🧊📄§ | 2026-05-05 | 2041-03-26 | 0 | 31 |
| 12616663 | Plant-derived exosome-like nanoparticles inhibit bacterial pathogenicity | 🖼🧊📄§ | 2026-05-05 | 2040-03-02 | 0 | 31 |
| 12617838 | Auto/allo-immune defense receptors for the selective targeting of activated pathogenic T cells and NK cells | 🖼🧊📄§ | 2026-05-05 | 2039-04-25 | 0 | 31 |
| 12617848 | Methods of treating ocular pathologies using bifunctional molecules that target growth factors | 🖼🧊📄§ | 2026-05-05 | 2041-11-08 | 0 | 31 |
| 12617834 | Composition of NY-ESO-1-specific t cell receptors restricted on multiple major histocompatibility complex molecules | 🖼🧊📄§ | 2026-05-05 | 2039-09-04 | 0 | 31 |
| 12617842 | Antiviral immunotherapy by membrane receptor ligation | 🖼🧊📄§ | 2026-05-05 | 2041-12-02 | 0 | 31 |
| 12617818 | Compositions and methods for modulating myosin subfragment-2 coiled coil stability and methods for using them | 🖼🧊📄§ | 2026-05-05 | 2041-03-25 | 0 | 31 |
| 12618067 | Targeted delivery of an inhibitor of miR-21 to macrophages for the treatment of pulmonary fibrosis | 🖼🧊📄§ | 2026-05-05 | 2041-04-09 | 0 | 31 |
| 12618840 | Antibody for detecting acetylation of COX2 protein, and uses thereof | 🖼🧊📄§ | 2026-05-05 | 2040-09-18 | 0 | 31 |
| 12618839 | Antibodies for detecting Epstein Barr virus-positive gastric cancer | 🖼🧊📄§ | 2026-05-05 | 2040-10-23 | 0 | 31 |
| 12617863 | Humanized anti-glycoprotein Ib alpha (GPIbalpha) antibodies | 🖼🧊📄§ | 2026-05-05 | 2040-12-10 | 0 | 31 |
| 12617860 | Anti-TNFR2 antibody and uses thereof | 🖼🧊📄§ | 2026-05-05 | 2041-01-05 | 0 | 31 |
| 12617868 | Activation of (Na++K+)-ATPase inhibits platelet aggregation and prevents thrombosis | 🖼🧊📄§ | 2026-05-05 | 2042-11-08 | 0 | 31 |
| 12620468 | Personalized liver cancer treatment | 🖼🧊📄§ | 2026-05-05 | 2045-03-06 | 0 | 31 |
| 12616742 | Recombinant heme oxygenase-1 (HO-1) for the treatment of sickle cell disease | 🖼🧊📄§ | 2026-05-05 | 2040-07-24 | 0 | 31 |
Page 1Next →